Regis Healthcare Ltd share price falls on court decision

The Regis Healthcare Ltd (ASX:REG) share price has dropped after revealing a court decision.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price has fallen after the initial positive start to the day. Regis Healthcare is one of Australia's largest aged care operators.

Today, the company announced an update on the Federal Court Judgement on Aged Care Legislation.

On 2 March 2018 the Federal Court of Australia decided that Regis' Asset Replacement Charge (ARC) was not consistent with the Aged Care Act 1997.

Following the judgement, Regis ceased charging the ARC effective 2 March 2018 and has now commenced a process to refund (with accrued interest) all residents who had previously paid the ARC.

Regis has previously advised that it made a provision in its FY17 financial accounts reducing profit by an amount equal to the amount of ARC revenue recognised. As a result, Regis said that there will be no impact on the net profit after tax (NPAT) and earnings before interest, tax, depreciation and amortisation (EBITDA) in FY18.

Ross Johnston, Regis' managing director, said "Regis believed it was important to seek clarity in relation to the Department of Health's guidance on these fees and charges and appreciates the Court's consideration of our application. We are refunding the fee, plus accrued interest, to all affected residents. Regis is in the process of contacting residents and/or their representatives directly."

Foolish takeaway

This judgement isn't really a surprise, but I can understand why Regis wanted to recoup lost revenue another way somehow. If you believe in the aged care sector as a good investment then I don't think this judgement changes the attractiveness of Regis as a long-term investment idea.

Motley Fool contributor Tristan Harrison owns shares of Regis Healthcare Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »